Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | — | — | — | — | — | — |
| Net income | -$1.23M | -$10.6M | -$12.7M | -$16.4M | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| EPS (diluted) | -$581.25 | -$22.07 | -$72.29 | -$39.76 | -$5.42 | -$4.08 | -$4.00 | -$1.50 | -$1.24 | -$1.25 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$202K | -$9.11M | -$10.6M | -$15.2M | -$13.5M | -$29.4M | -$37.6M | -$24.5M | -$29.8M | -$49.5M |
| Capital expenditures | $46.0K | — | $46.0K | $53.0K | $17.0K | — | — | $21.0K | — | $3.00K |
| Free cash flow | -$248K | — | -$10.7M | -$15.3M | -$13.5M | — | — | -$24.5M | — | -$49.5M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15.0K | $5.28M | $9.52M | $16.7M | $35.9M | $43.0M | $24.8M | $15.5M | $12.8M | $20.9M |
| Total assets | $3.81M | $9.89M | $19.1M | $21.1M | $40.3M | $47.5M | $30.0M | $19.4M | $38.6M | $41.8M |
| Total liabilities | $3.20M | $2.01M | $3.28M | $3.03M | $3.01M | $19.5M | $21.7M | $20.8M | $17.7M | $20.3M |
| Shareholders' equity | $610K | $15.8M | $15.8M | $18.1M | $37.3M | $28.0M | $8.30M | -$1.45M | $20.9M | $21.5M |
| Retained earnings | -$2.06M | -$12.7M | -$25.4M | -$45.7M | -$60.4M | -$93.6M | -$136M | -$166M | -$206M | -$260M |
| Shares (wtd avg diluted) | 21.2B | 1.19M | 6.72M | 1.47M | 2.72M | 8.12M | 10.6M | 19.8M | 32.1M | 43.6M |
Every figure is extracted from ACHIEVE LIFE SCIENCES, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.